ARTHEx Biotech
PrivateLast Round
Series B
Sep 17, 2025
Total Funding Raised
$95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ARTHEx Biotech is a biotechnology company that develops targeted RNA medicines for rare genetic neuromuscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTHEx Biotech Comparables
Compare ARTHEx Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 83% | |
| PepGen | 81% | |
| Juvena Therapeutics | 81% |
ARTHEx Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 17, 2025 | ||||
| Series A | Jul 20, 2022 | ||||
| Seed | Jul 23, 2020 | ||||
| Seed | Jun 1, 2020 |
Key People
Founding team and executive leadership
ARTHEx Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B |
| Hadean Ventures | Series B |
| Center for Technological Development and Innovation | Seed, Series B |
| Invivo Partners | Seed, Series B |
| Columbus Venture Partners | Series B |
| European Union Funding Programmes | Series B |
| Bpifrance | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 117% MoM.
- May 17, 2026
Monthly visitors increased 67% MoM.
ARTHEx Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ARTHEx Biotech's valuation, stock price, and market status.
Is ARTHEx Biotech a public or private company?
ARTHEx Biotech is a private company.
What is the current stock price of ARTHEx Biotech?
ARTHEx Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is ARTHEx Biotech worth (valuation)?
Valuation information for ARTHEx Biotech is not publicly available.
Can I buy ARTHEx Biotech stock?
ARTHEx Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ARTHEx Biotech's last funding round?
ARTHEx Biotech's most recent funding round was Series B on September 17, 2025.
Who are the main investors in ARTHEx Biotech?
Key investors in ARTHEx Biotech include Invivo Partners, Bpifrance, AdBio partners.
Will ARTHEx Biotech IPO soon?
No public IPO plans have been announced for ARTHEx Biotech.
How can I track ARTHEx Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ARTHEx Biotech's secondary market activity and sign up for updates.